BP
GNTX icon

Ballentine Partners’s Gentex GNTX Stock Holding History

Ballentine Partners’s Portfolio GNTX Stock Details GNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,878
Closed -$212K – 777
2024
Q1 		$212K Buy
+5,878
New +$203K ﹤0.01% 654

Other funds holding GNTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Ballentine Partners's GNTX Position: Q2 2024 in Review

Ballentine Partners sold out of Gentex (GNTX) in Q2 2024, closing a stake of 5,878 shares — an estimated $212K sold.

Ballentine Partners first reported a position in GNTX in Q1 2024 and held it in 1 quarter. The position peaked at $212K in Q1 2024. 534 funds tracked by Wall St. Rank hold GNTX as of Q2 2024.

  • Ballentine Partners reported no remaining Gentex position as of Q2 2024 after selling out during the quarter.
  • Ballentine Partners sold 5,878 Gentex shares in Q2 2024, an estimated $212K.
  • Ballentine Partners first reported a position in Gentex in Q1 2024 and held it in 1 quarter.
  • Ballentine Partners's Gentex position peaked at $212K in Q1 2024.
  • 534 funds tracked by Wall St. Rank held Gentex as of Q2 2024.

Based on Ballentine Partners's 13F filing for Q2 2024, filed 6 Aug 2024.